Predictors of methamphetamine injection in out-of-treatment IDUs.
From 2004-2006, 439 injection drug users were recruited in Denver, Colorado, to participate in a study of drug use and HCV risk. Over two-thirds were male, more than half were white, and 28% were methamphetamine injectors. The Risk Behavior Assessment, which assesses demographics, drug use, and HIV risk behaviors, was used. Variables were assessed for association with methamphetamine (MA) injection. A logistic regression model was built using forward stepwise method to determine independent associations between variables of interest and MA injection. The study's limitations are noted, and implications are described.
Corsi
Karen F
KF
Department of Psychiatry, School of Medicine, University of Colorado at Denver and Health Sciences Center, Denver, Colorado 80206, USA. Karen.corsi@uchsc.edu
Kwiatkowski
Carol F
CF
Booth
Robert E
RE
D000328:Adult; D000553:Ambulatory Care; D003120:Colorado; D015259:Dopamine Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D005260:Female; D006526:Hepatitis C; D006801:Humans; D007407:Interviews as Topic; D016015:Logistic Models; D008297:Male; D008694:Methamphetamine / Q000008:administration & dosage* / Q000627:therapeutic use; D008875:Middle Aged; D016017:Odds Ratio; D010379:Peer Group; D018570:Risk Assessment; D012309:Risk-Taking; D015819:Substance Abuse, Intravenous / Q000188:drug therapy*
D015259:Dopamine Agents; D008694:Methamphetamine